Columbus CyberKnife Medical Director Dr. Doug Widman recently participated on a speakers panel for the Cancer Support Community’s Shoulder to Shoulder event, a men’s health program focused on sharing information related to men’s cancers. Dr. Widman discussed CyberKnife as a treatment option for prostate cancer.
As a disease that annually takes the lives of more people than breast, prostate, colon and pancreatic cancers combined, lung cancer will kill more than 156,000 people in the United States this year, according to the American Cancer Society. Additionally, about a quarter of a million people will face a lung cancer diagnosis.
November is Lung Cancer Awareness Month — a time to take action, quit smoking, educate loved ones and raise awareness for the leading cause of cancer deaths in men and women.
One in six men will be diagnosed with prostate cancer in his lifetime while one in 36 men will die of the disease, which the American Cancer Society names as the second leading cause of cancer deaths in men. This year alone nearly 250,000 men will face a prostate cancer diagnosis.
In Franklin County, about 168 of every 100,000 men are affected, compared to 146 of every 100,000 statewide, according to the National Cancer Institute.
Columbus CyberKnife celebrates its one-year anniversary this month with the announcement of several milestones following its first year treating patients on the campus of Mount Carmel St. Ann’s Hospital. As part of a $6.3 million investment, Columbus CyberKnife established the first CyberKnife program in the greater Columbus area.
Columbus CyberKnife recently sponsored the American Lung Association’s Fight For Air Walk in Columbus on June 4, 2011. The event attracted approximately 200 people who participated in the 5k walk to increase awareness and raise money for the American Lung Association’s fight against lung disease. CyberKnife is an important noninvasive treatment option for lung cancer, and our center is proud to have supported this event benefitting the American Lung Association.
More than 575 people in the U.S. are diagnosed with a primary or metastatic brain tumor each day. May is National Brain Tumor Awareness Month and was first established by the U.S. House of Representatives in 2008. It is a time when many individuals and organizations focus on raising awareness of brain tumors, increasing funding for research and educating the public on symptoms and treatment options.
Nearly 600 diagnoses each day mean more than 210,000 people are diagnosed with a brain tumor each year, according to the National Brain Tumor Society.
Dr. Widman of Columbus CyberKnife appeared on NBC4′s Daytime Columbus on March 18, 2011.
Mount Carmel has invested in a new technology known as the SuperDimension i-Logic System, which uses special electromagnetic software to perform biopsies of tumors deep in the lungs. The machine extends the reach of conventional equipment and enables physicians to diagnose benign and malignant tumors with minimal invasiveness. The i-Logic System provides the ability to detect lung cancer earlier, enhancing treatment options such as CyberKnife for patients. It also minimizes the need for more invasive, surgical procedures sometimes needed to access difficult-to-reach areas of the lungs. This new technology has also been used more frequently to place fiducials, or tissue markers, commonly used in CyberKnife lung cancer procedures to help the machine track the position of a tumor throughout treatment. As a service of Mount Carmel St. Ann’s hospital, Columbus CyberKnife lung cancer patients will have access to this advanced technology.
Medical Director Dr. Doug Widman speaks to a group of foreign radiation oncologists with the Columbus International Visitors Council during a recent tour of the CyberKnife center. Pictured with the CyberKnife, Dr. Widman explains how the technology offers important noninvasive treatment options for patients.
Local television coverage of Columbus CyberKnife center on Daytime Columbus.